The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Impaired Fasting Glucose in Nondiabetic Range: Is It a Marker of Cardiovascular Risk Factor Clustering?
Abstract
Background. Impaired fasting glucose (IFG) through the nondiabetic range (100–125 mg/dL) is not considered in the cardiovascular (CV) risk profile. Aim. To compare the clustering of CV risk factors (RFs) in nondiabetic subjects with normal fasting glucose (NFG) and IFG. Material and Methods. Cross-sectional study in 3739 nondiabetic subjects. Demographics, medical history, and CV risk factors were collected and lipid profile, fasting glucose levels (FBG), C-reactive protein (hsCRP), blood pressure (BP), anthropometric measurements, and aerobic capacity were determined. Results. 559 (15%) subjects had IFG: they had a higher mean age, BMI, waist circumference, non-HDL cholesterol, BP, and hsCRP (p<0.0001) and lower HDL (p<0.001) and aerobic capacity (p<0.001). They also had a higher prevalence of hypertension (34% versus 25%; p<0.001), dyslipidemia (79% versus 74%; p<0.001), and obesity (29% versus 16%; p<0.001) and a higher Framingham risk score (8% versus 6%; p<0.001). The probability of presenting 3 or more CV RFs adjusted by age and gender was significantly higher in the top quintile of fasting glucose (≥98 mg/dL; OR = 2.02; 1.62–2.51). Conclusions. IFG in the nondiabetic range is associated with increased cardiovascular RF clustering.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Impaired fasting serum glucose in the nondiabetic range has also been associated with subclinical CVD [30].”
From Nutritional Status and Cardiovascular Health in Female Adolescent Elite-Level Artistic Gymnasts and Swimmers: A Cross-Sectional Study of 31 Athletes (2021) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Folsom, A. R., Yatsuya, H., Nettleton, J. A., Lutsey, P. L., Cushman, M., & Rosamond, W. D. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.11.041 · Cited by 713
Levitan, E. B., Song, Y., Ford, E. S., & Liu, S. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.19.2147 · Cited by 668
Fasting and Postchallenge Glycemia and Cardiovascular Disease Risk
Meigs, J. B., Nathan, D. M., D’Agostino, R. B., & Wilson, P. W. F. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1845 · Cited by 509
Research works printed but not linked: 14
- 10.1016/s0140-6736(10)60484-9 · DOI · Paper page
- 10.1161/circulationaha.107.720847 · DOI · Paper page
- 10.1161/circulationaha.109.192644 · DOI · Paper page
- 10.1371/journal.pone.0072763 · DOI
- 10.4067/s0718-85602009000300001 · DOI
- 10.1161/01.HYP.0000032853.95690.26 · DOI
- 10.1001/jama.289.19.2560 · DOI · Paper page
- 10.1161/01.cir.97.18.1837 · DOI · Paper page
- 10.1161/circulationaha.114.010815 · DOI
- 10.1001/archinte.162.2.209 · DOI
- 10.1016/s0002-9149(01)02302-5 · DOI
- 10.4067/S0034-98872010000600007 · DOI
- 10.1001/jama.2009.681 · DOI · Paper page
- 10.1016/j.pcad.2013.09.002 · DOI · Paper page
Cited by
Jakše, B., Jakše, B., Mis, N. F., Jug, B., Šajber, D., Godnov, U., & Čuk, I. (2021) · Journal of Nutrition and Metabolism · doi:10.1155/2021/8810548 · Cited by 21
Metadata
- Authors
- Valentino, G., Kramer, V., Orellana, L., Bustamante, M. J., Casasbellas, C., Adasme, M., Salazar, A., Navarrete, C., & Acevedo, M.
- Venue
- Disease Markers
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-5
- ISSN
- 0278-0240
- 1875-8630
- Cited by
- 8
- References
- 4
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
